Computer simulations of Alzheimer's amyloid β-protein folding and assembly

Current Alzheimer Research

Volumn 3, Issue 5, 2006, Pages 493-504

  Urbanc, Brigita ^a   Cruz, Luis ^a   Teplow, David B ^b   Stanley, H Eugene ^a  

^a Boston University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Coarse grained protein model; Computer simulations; Fibril formation; Oligomer formation; Protein folding

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DIMER;

ALZHEIMER DISEASE; COMPUTER SIMULATION; DIMERIZATION; IN VITRO STUDY; MOLECULAR DYNAMICS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; COMPUTER SIMULATION; HUMANS; MODELS, CHEMICAL;

EID: 33846073514     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720506779025170     Document Type: Review

References (149)

1. Kidd M. Alzheimer's disease - an electron microscopical study. Brain 87: 307-320 (1964).
2. Terry RD, Gonatas NK and Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 44: 269-297 (1964).
3. Glenner GG and Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 122: 1131-1135 (1984).
4. Hardy J and Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356 (2002).
5. Kamino K, Orr HT, Payami H, Wijsman EM, Alonso E, Pulst SM, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51: 998-1014 (1992).
6. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos LJr, Eckman C, et al. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (β-APP(717)) mutants. Science 264: 1336-1340 (1994).
7. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870 (1996).
8. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487-1491 (2001).
9. Gotz J, Chen F, van Dorpe J and Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Aβ 42 fibrils. Science 293: 1491-1495 (2001).
10. Oddo S, Billings L, Kesslak JP, Cribbs DH and LaFerla FM. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43: 321-332 (2004).
11. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M and Ashe KH. A specific amyloid β-protein assembly in the brain impairs memory. Nature Lett 440: 352-357 (2006).
12. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359: 325-327 (1992).
13. Gravina SA, Ho LB, Eckman CB, Long KE, Otvos LJr, Younkin LH, et al. Amyloid β-protein (Aβ) in Alzheimer's disease brain - Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ-40 or Aβ-42(43). J Biol Chem 270: 7013-7016 (1995).
14. Cohen AS and Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183: 1202-1203 (1959).
15. Kirschner DA, Abraham C and Selkoe DJ. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc Natl Acad Sci USA 83: 503-507 (1986).
16. Lazo ND, Maji SK, Fradinger EA, Bitan G and Teplow DB. The amyloid β-protein In 'Amyloid Proteins-The Beta Sheet Conformation and Disease' (Ed Sipe JC), Wiley-VCH, Weinheim, p. 385-492 (2005).
17. Morgan C, Colombres M, Nuñez MT and Inestrosa NC. Structure and function of amyloid in Alzheimer's disease. Prog in Neurobiol 74: 323-349 (2004).
18. Tsang BP, Kitazawa M and LaFerla FM. Amyloid β-peptide: the inside story Curr Alzh Res 1: 231-239 (2004).
19. Pike CJ, Walencewicz AJ, Glabe CG and Cotman CW. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity Brain Res 563: 311-314 (1991).
20. Walsh DM, Lomakin A, Benedek GB, Condron MM and Teplow DB. Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate. J Biol Chem 272: 22364-22372 (1997).
21. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, et al. Amyloid β-protein fibrillogenesis - Structure and biological activity of protofibrillar intermediates. J Biol Chem 274: 25945-25952 (1999).
22. 1-42 into globular neurotoxins. Biochemistry 42: 12749-12760 (2003).
23. Klein WL. ADDLs & protofibrils - the missing links? Neurobiol Aging 23: 231-233 (2002).
24. Klein WL, Stine WBJr and Teplow DB. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging 25: 569-580 (2004).
25. Glabe CG. Amyloid accumulation and pathogensis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar Aβ. Subcell Biochem 38: 167-177 (2005).
26. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Aβ(1-42) are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453 (1998).
27. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid β-protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539 (2002).
28. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, et al. Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100: 10417-10422 (2003).
29. Demuro A, Mina E, Kayed R, Milton SC, Parker I and Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280: 17294-17300 (2005).
30. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84 (2005).
31. Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Jansen B, et al. Globular amyloid β-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95: 834-847 (2005).
32. Chimon S and Ishii Y. Capturing intermediate structures of Alzheimer's β-amyloid, Aβ(1-40), by solid-state NMR spectroscopy. J Am Chem Soc 127: 13472-13473 (2005).
33. Lomakin A and Teplow DB. Quasielastic scattering study of amyloid β-protein fibril formation. Prot Pept Lett 13: 247-254 (2006).
34. Karplus M. Molecular dynamics of biological macromolecules: a brief history and perspective. Biopolymers 68: 350-358 (2003).
35. Schleif R. Modeling and studying protein with molecular dynamics. Methods Enzymol 383: 28-47 (2004).
36. Levitt M. A simplified representation of protein conformations for rapid simulation of protein folding. J. Mol Biol 104: 59-107 (1976).
37. Head-Gordon T and Brown S. Minimalist models for protein folding and design. Curr Opin Struct Biol 13: 160-167 (2003).
38. Tozzini V. Coarse-grained models for proteins. Curr Opin Struct Biol 15: 144-150 (2005).
39. Ding F and Dokholyan NV. Simple but predictive protein models. Trends Biotech 23: 450-455 (2005).
40. Hansmann UHE and Okamoto Y. New Monte Carlo algorithms for protein folding. Curr Opin Struct Biol 9: 177-183 (1999).
41. Takada S, Luthey-Schulten Z and Wolynes PG. Folding dynamics with nonadditive forces: A simulation study of a designed helical protein and a random heteropolymer. J Chem Phys 110: 11616-11629 (1999).
42. Brown S, Fawzi NJ and Head-Gordon T. Coarse-grained sequences for protein folding and design. Proc Natl Acad Sci USA 100: 10712-10717 (2003).
43. Takagi F, Koga N and Takada S. How protein thermodynamics and folding mechanisms are altered by the chaperonin cage: Molecular simulations. Proc Natl Acad Sci USA 100: 11367-11372 (2003).
44. Fawzi NL, Chubukov V, Clark LA, Brown S and Head-Gordon T. Influence of denatured and intermediate states of folding and protein aggregation. Prot Sci 14: 993-1003 (2005).
45. Mukherjee A and Bagchi B. Contact pair dynamics during folding of two small proteins: Chicken villin head piece and the Alzheimer protein β-amyloid. J Chem Phys 120: 1602-1612 (2004).
46. Okamoto Y. Generalized-ensemble algorithms: enhanced sampling techniques for Monte Carlo and molecular dynamics simulations. J Mol Graph Mod 22: 425-439 (2004).
47. Mezei M. Adaptive umbrella sampling - self-consistent determination of the non-Boltzmann bias. J Comput Phys 68: 237-248 (1987).
48. Hansmann UHE, Okamoto Y and Eisenmenger F. Molecular dynamics, Langevin and hybrid Monte Carlo simulations in a multicanonocal ensemble. Chem Phys Lett 259: 321-330 (1996).
49. Nakajima N, Nakamura H and Kidera A. Multicanonical ensemble generated by molecular dynamics simulation for enhanced conformational sampling of peptides. J Phys Chem 101: 817-824 (1997).
50. Bartels C and Karplus M. Probability distributions for complex systems: adaptive umbrella sampling of the potential energy. J Phys Chem B 102: 865-880 (1998).
51. Sugita Y and Okamoto Y. Replica-exchange molecular dynamics for protein folding. J Chem Phys 314: 141-151 (1999).
52. Marinari E and Parisi G. Simulated tempering: a new Monte Carlo scheme. Europhys Lett 19: 451-458 (1992).
53. Kumar S, Bouzida D, Swendsen RH, Kollman PA and Rosenberg JM. The weighted histogram analysis method for free-energy calculations on biomolecules. J Comput Chem 13: 1011-1021 (1992).
54. Schaefer M, Bartels C and Karplus M. Solution Conformations and Thermodynamics of Structured Peptides: Molecular Dynamics Simulation with an Implicit Solvation Model. J Mol Biol 284: 835-848 (1998).
55. Baumketner A and Shea JE. Free Energy Landscape for Amyloidogenic Tetrapeptides Dimerization. Biophys J 89: 1493-1503 (2005).
56. Barkema GT and Mousseau N. Event-based relaxation of continuous disordered systems. Phys Rev Lett 77: 4358-4361 (1996).
57. Malek R and Mousseau N. Dynamics of Lenard-Jones clusters: A characterization of the activation-relaxation technique. Phys Rev E 62: 7723-7728 (2000).
58. Wei GH, Mousseau N and Derreumaux P. Exploring the energy landscape of proteins: a characterization of the activationrelaxation technique. J Chem Phys 117: 11379-11387 (2002).
59. Mousseau N and Derremaux P. Exploring the Early Steps of Amyloid Peptide Aggregation by Computers Acc Chem Res 38: 885-891 (2005).
60. Rapaport DC. The art of molecular dynamics simulation Cambridge University Press (1997).
61. Zhou Y, Hall CK and Karplus M. First-Order Disorder-to-Order Transition in an Isolated Homopolymer. Model Phys Rev Lett 77: 2822-2825 (1996).
62. Zhou Y and Karplus M. Folding thermodynamics of a three-helixbundle protein. Proc Natl Acad Sci USA 94: 14429-14432 (1997).
63. Zhou Y, Karplus M, Wichert JM and Hall CK. Equilibrium thermodynamics of homopolymers and clusters: molecular dynamics and Monte-Carlo simulations of system with square-well interactions. J Chem Phys 107: 10691-10708 (1997).
64. Dokholyan NV, Buldyrev SV, Stanley HE and Shakhnovich EI. Discrete molecular dynamics studies of folding of a protein-like model. Fold Des 3: 577-587 (1998).
65. Zhou Y and Karplus M. Folding of a Model Three-helix Bundle Protein: A Thermodynamic and Kinetic Analysis. J Mol Biol 293: 917-951 (1999).
66. Dokholyan NV, Buldyrev SV, Stanley HE and Shakhnovich EI. Identifying the protein folding nucleus using molecular dynamics. J Mol Biol 296: 1183-1188 (2000).
67. Smith AV and Hall CK. α-helix formation: discontinuous molecular dynamics on an intermediate-resolution protein model Proteins 44: 344-360 (2001).
68. Smith AV and Hall CK. Assembly of a Tetrameric α-Helical Bundle: Computer Simulations on an Intermediate-Resolution Protein Model Proteins 44: 376-391 (2001).
69. Smith AV and Hall CK. Protein refolding versus aggregation: Computer simulations on an intermediate-resolution protein model. J Mol Biol 312: 187-202 (2001).
70. Ding F, Borreguero JM, Buldyrev SV, Stanley HE and Dokholyan NV. A Mechanism for the α-helix to β-hairpin transition Proteins: Structure, Function, and Genetics 53: 220-228 (2003).
71. Ding F, Buldyrev SV and Dokholyan NV. Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model. Biophys J 88: 147-155 (2005).
72. Borreguero JM, Urbanc B, Lazo ND, Buldyrev SV, Teplow DB and Stanley HE. Discrete molecular dynamics study of the amyloid β-protein decapeptide Aβ(21-30). Proc Natl Acad Sci USA 102: 6015-6020 (2005).
73. Urbanc B, Borreguero JM, Cruz L and Stanley HE. Amyloid β-Protein Aggregation: Ab Initio Discrete Molecular Dynamics Approaches. Meth. Enzymol. 412: 314-338 (2006).
74. Lazo ND, Grant MA, Condron MC, Rigby AC and Teplow DB. On nucleation of amyloid β-protein monomer folding. Prot Sci 14: 1581-1596 (2005).
75. Lazo ND and Downing DT. Fibril formation by amyloid-β proteins may involve β-helical protofibrils. J Pept Res 53: 633-640 (1999).
76. Lansbury PTJr, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, et al. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a Cterminal peptide. Nat Struct Biol 2: 990-998 (1995).
77. Wesson L and Eisenberg D. Atomic solvation parameters applied to molecular dynamics of proteins in solution. Protein Science 1: 227-235 (1992).
78. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, et al. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99: 16742-16747 (2002).
79. Cruz L, Urbanc B, Borreguero JM, Lazo ND, Teplow DB and Stanley HE. Solvent and mutation effects on the nucleation of amyloid β-protein folding. Proc Natl Acad Sci USA 102: 18258-18263 (2005).
80. Baumketner A, Bernstein SL, Wyttenbach T, Lazo ND, Teplow DB, Bowers MT, et al. Structure of the 21-30 fragment of amyloid β-protein. Prot Sci 15: 1239-1247 (2006).
81. Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, et al. The Alzheimer's peptide Aβ adopts a collapsed coil structure in water. J Struct Biol 130: 130-141 (2000).
82. Coles M, Bicknell W, Watson AA, Fairlie DP and Craik DJ. Solution structure of amyloid-β peptide (1-40) in a water-micelle environment Is the membrane spanning domain where we think it is? Biochemistry 37: 11064-11077 (1998).
83. Crescenzi O, Tomaselli S, Guerrini R, Salvatori S, D'Ursi AM, Temussi PA, et al. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment Similarity with a virus fusion domain. Eur J Biochem 269: 5642-5648 (2002).
84. Massi F, Peng JW, Lee JP and Straub JE. Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys J 80: 31-44 (2001).
85. Massi F and Straub JE. Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's β-amyloid peptide. Biophys J 81: 697-709 (2001).
86. Wisniewski T, Ghiso J and Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 179: 1247-1254 (1991).
87. Teplow DB, Lomakin A, Benedek GB, Kirschner DA and Walsh DM. Effects of β-protein mutations on amyloid fibril nucleation and elongation In 'Alzheimer's Disease: Biology, Diagnosis and Therapeutics' (Eds: Iqbal K, Winblad B, Nishimura T, Takeda M and Wisniewski HM) John Wiley & Sons Ltd., Chichester, England, p. 311-319 (1997).
88. Massi F, Klimov D, Thirumalai D and Straub JE. Charge states rather than propensity for β-structure determine enhanced fibrillogenesis in wild-type Alzheimer's β-amyloid peptide compared to E22Q Dutch mutant. Prot Sci 11: 1639-1647 (2002)
89. Massi F and Straub JE. Structural and dynamical analysis of the hydration of the Alzheimer's β-amyloid peptide. J Comput Chem 24: 143-153 (2002)
90. Straub JE, Guevara J, Huo S and Lee JP. Long time dynamic simulations: exploring the folding pathways of an Alzheimer's amyloid Aβ-peptide. Acc Chem Res 35: 473-481 (2002).
91. Han W and Wu YD. A strand-loop-strand structure is possible intermediate in fibril elongation: long time simulations of amyloid β-peptide (10-35). J. Am. Chem Soc 127: 15408-15416 (2005).
92. 1-40 peptide in water: uncoupling β-structure folding from aggregation. Biochim Biophys Acta 1476: 93-102 (2000).
93. Sali A, Shakhnovich E and Karplus M. How do proteins fold? Nature 369: 248-251 (1994).
94. Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB and Stanley HE. In silico study of amyloid β-protein (Aβ) folding and oligomerization. Proc Natl Acad Sci USA 101: 17345-17350 (2004).
95. Weinreb PH, Jarrett JT and Lansbury PTJr Peptide models of a hydrophobic cluster at the C-terminus of the β-amyloid protein. J Am Chem Soc 116: 10835-10836 (1994).
96. Xu Y, Shen J, Luo X, Zhu W, Chen K, Ma J, et al. Conformational transition of amyloid β-peptide. Proc Natl Acad Sci USA 102: 5403-5407 (2005).
97. Flöck D, Colacino S, Colombo G and Di Nola A. Misfolding of the Amyloid β-protein: A Molecular Dynamics Study. Proteins 62: 183-192 (2006).
98. Baumketner A, Bernstein SL, Wyttenbach T, Bitan G, Teplow DB, Bowers MT and Shea JE. Amyloid β-protein monomer structure: a computational and experimental study. Prot Sci 15: 420-428 (2006).
99. Kirkitadze MD, Condron MM and Teplow DB. Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. J Mol Biol 312: 1103-1119 (2001).
100. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J and Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils. Proc Natl Acad Sci USA 97: 13045-13050 (2000).
101. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, et al. Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: Evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance. Biophys J 83: 1205-1216 (2002).
102. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, et al. Propagating structure of Alzheimer's β-amyloid (10-35) is parallel β-sheet with residues in exact register. Proc Natl Acad Sci USA 95: 13407-13412 (1998).
103. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, et al. Two-dimensional structure of β-amyloid(10-35) fibrils. Biochemistry 39: 3491-3499 (2000).
104. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, et al. Amyloid fibril formation by Aβ(16-22), a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39: 13748-13759 (2000).
105. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM and Tycko R. Solid state NMR reveals a pH-dependent antiparallel β-sheet registry in fibrils formed by a β-amyloid peptide. J Mol Biol 335: 247-260 (2004).
106. Gordon DJ, Balbach JJ, Tycko R and Meredith SC. Increasing the amphiphilicity of an amyloidogenic peptide changes the β-sheet structure in the fibrils from antiparallel to parallel. Biophys J 86: 428-434 (2004).
107. 10-35): Sequence effect. Proc Natl Acad Sci USA 99: 14126-14131 (2002).
108. 16-22 amyloid peptides into antiparallel β-sheets. Structure 11: 295-307 (2003).
109. 16-22 oligomers. Proc Natl Acad Sci USA 101: 14760-14765 (2004).
110. 16-22 Peptide into β-Sheets. J Am Chem Soc 126: 11509-11516 (2004).
111. 16-22. Peptide Assembly Structure 12: 1245-1255 (2004).
112. Tjernberg LO, Tjernberg A, Bark N, Shi Y, Ruzsicska BP, Bu Z, et al. Assembling amyloid fibrils from designed structures containing a significant amyloid β-peptide fragment. Biochem J 366: 343-351 (2002).
113. Hwang W, Zhang S, Kamm RD and Karplus M. Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci USA 101: 12916-12921 (2004).
114. 16-22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J 87: 3657-3664 (2004).
115. Gnanakaran S, Nussinov R and García AE. Atomic-level description of amyloid β-dimer formation. J Am Chem Soc 128: 2158-2159 (2006).
116. Tarus B, Straub JE and Thirumalai D. Probing the initial stage of aggregation of the Aβ(10-35)-protein: Assessing the propensity for peptide dimerization. J Mol Biol 345: 1141-1156 (2005).
117. Sciarretta KL, Gordon DJ, Petkova AT, Tycko R and Meredith SC. Aβ40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry 44: 6003-6014 (2005).
118. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP and Tycko R. Self-Propagating, Molecular-Level Polymorphism in Alzheimer's β-Amyloid Fibrils. Science 307: 262-265 (2005).
119. Lührs TL, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli H, et al. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc Natl Acad Sci USA 102: 17342-17347 (2005).
120. Palmblad M, Westlind-Danielsson A and Bergquist J. Oxidation of methionine 35 attenuates formation of amyloid β-peptide 1-40 oligomers. J Biol Chem 277: 19506-19510 (2002).
121. Hou L, Kang I, Marchant RE and Zagorski MG. Methionine 35 oxidation reduces fibril assembly of the amyloid Aβ-(1-42) peptide of Alzheimer's disease. J Biol Chem 277: 40173-40176 (2002).
122. 35 and amyloid β-protein oligomerization. J Am Chem Soc 125: 15359-15365 (2003).
123. Hou L, Shao H, Zhang Y, Li H, Menon NK, Neuhaus EB, et al. Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J Am Chem Soc 126: 1992-2005 (2004).
124. Butterfield DA and Boyd-Kimball D. The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703: 149-156 (2005)
125. Massi F and Straub JE. Energy landscape theory for Alzheimer's amyloid β-peptide fibril elongation. Proteins 42: 217-229 (2001).
126. Lomakin A, Chung DS, Benedek GB, Kirschner DA and Teplow DB. On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 93: 1125-1129 (1996).
127. Lomakin A, Teplow DB, Kirschner DA and Benedek GB. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc Natl Acad Sci USA 94: 7942-7947 (1997).
128. Kusumoto Y, Lomakin A, Teplow DB and Benedek GB. Temperature dependence of amyloid β-protein fibrillization. Proc Natl Acad Sci USA 95: 12277-12282 (1998).
129. Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, Lee JP, et al. Alzheimer's Disease Amyloid Propagation by a Template-Dependent Dock-Lock Mechanism. Biochemistry 39: 6288-6295 (2000).
130. Jarrett JT and Lansbury PTJr Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058 (1993).
131. Barrow CJ, Yasuda A, Kenny PTM and Zagorski MG. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease - Analysis of circular-dichroism spectra. J Mol Biol 225: 1075-1093 (1992).
132. Zhang SS, Casey N and Lee JP. Residual Structure in the Alzheimer's Disease Peptide - Probing the Origin of a Central Hydrophobic. Cluster Fold Des 3: 413-422 (1998).
133. Simona F, Tiana G, Broglia RA and Colombo G. Modeling the α-helix to β-hairpin transition mechanism and the formation of oligomeric aggregates of the fibrillogenic peptide Aβ(12-28): insights from all-atom molecular dynamics simulations. J Mol Graph Mod 23: 263-273 (2004).
134. Buchete NV, Tycko R and Hummer G. Molecular Dynamics Simulations of Alzheimer's β-Amyloid Protofilaments. J Mol Biol 353: 804-821 (2005)
135. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB and Teplow DB. Amyloid β-protein (Aβ) assembly: Aβ-40 and Aβ-42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100: 330-335 (2003).
136. Bitan G, Lomakin A and Teplow DB. Amyloid β-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 276: 35176-35184 (2001).
137. Bitan G and Teplow DB. Rapid photochemical cross-linking - A new tool for studies of metastable, amyloidogenic protein assemblies. Acc Chem Res 37: 357-364 (2004).
138. Bitan G, Vollers SS and Teplow DB. Elucidation of primary structure elements controlling early amyloid β-protein oligomerization. J Biol Chem 278: 34882-34889 (2003).
139. 19 Alloform. J Am Chem Soc 127: 2075-2084 (2005).
140. Valerio M, Colosimo A, Conti F, Giuliani A, Grottesi A, Manetti C, et al. Early Events in Protein Aggregation: Molecular Flexibility and Hydrophobibic/Charge Interaction in Amyloid Peptides as Studied by Molecular Dynamics Simulations. Proteins 58: 110-118 (2005).
141. Zbilut JP, Colosimo A, Conti F, Colafranceschi M, Manetti C, Valerio M, et al. Protein Aggregation/Folding: The Role of Deterministic Singularities of Sequence Hydrophobicity as Determined by Nonlinear Signal Analysis of Acylphosphatase and Aβ(1-40). Biophys J 85: 3544-3557 (2003).
142. Peng S, Ding F, Urbanc B, Buldyrev SV, Cruz L, Stanley HE, et al. Discrete molecular dynamics simulations of peptide aggregation. Phys Rev E 69: 041908 (2004).
143. Urbanc B, Cruz L, Ding F, Sammond D, Khare S, Buldyrev SV, et al. Molecular Dynamics Simulation of Amyloid-β Dimer Formation. Biophys J 87: 2310-2321 (2004).
144. Snow CD, Sorin EJ, Rhee YM, and Pande VS. How well can simulation predict protein folding kinetic and thermodynamics? Ann Rev Biophys Biomol Struct 34: 43-69 (2005).
145. Nelson R and Eisenberg D. Recent atomic models of amyloid fibril structure. Curr Opin Struct Biol 16: 260-265 (2006).
146. Cheung MS, Klimov D and Thirumalai D. Molecular crowding enhances native state stability and refolding rates of globular proteins. Proc Natl Acad Sci USA 102: 4753-4758 (2005).
147. Nguyen HD and Hall CK. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 101: 16180-16185 (2004).
148. Nguyen HD and Hall CK. Phase diagrams describing Fibrillization by Polyalanine Peptides. Biophys J 87: 4122-4134 (2004).
149. Nguyen HD and Hall CK. Kinetics of Fibril Formation by Polyalanine Peptides. J Biol Chem 280: 9074-9082 (2005).